ArticleThe oncologist2025

Genomic alterations and associated outcomes in patients with PSMA-positive metastatic castration-resistant prostate cancer treated with 177Lu-PSMA-617.

Justine Panian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.